The latest cancer therapies to be added to the interaction checker are:
- Ibrutinib
- Idelalisib
- Infigratinib
- Ipilimumab
This takes the total of new cancer drugs to 37 since we started the project of adding new drugs to the Cancer Therapies class in May this year.
